I'd say the Google results are about as much as you could expect for a small biotech company with a generic name like "Antisense Therapeutics." Many of the results are about antisense therapy in general, rather than ANP. It's not something I'm too worried about at the moment. Once Phase IIB gets underway I'd imagine we'll get a lot more media coverage and therefore more Google hits.
I'm not sure what ANP's US-based Investor Relations Director Erin Cox is doing to earn her pay. Doesn't seem like much. She joined ANP in 2018 according to her LinkedIn. She had previously worked for Sarepta under Goolsbee. Perhaps Goolsbee brought her along? I wouldn't mind bringing on some heavier hitters in the US.
While ANP seems to be taking a very staid, conservative approach to stock promotion, which may pay off in the long run in terms of company credibility, it can be maddening as a shareholder.
Chart, page-2299
-
-
- There are more pages in this discussion • 3,607 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.9¢ |
Change
-0.002(2.47%) |
Mkt cap ! $81.90M |
Open | High | Low | Value | Volume |
8.0¢ | 8.1¢ | 7.8¢ | $1.034M | 12.98M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 349999 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 305419 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 349999 | 0.079 |
13 | 925066 | 0.078 |
11 | 938445 | 0.077 |
6 | 776200 | 0.076 |
12 | 1232581 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 305419 | 1 |
0.081 | 550144 | 3 |
0.082 | 599880 | 3 |
0.084 | 400000 | 1 |
0.085 | 40000 | 1 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |